Posted by: Yen Thieu in Worldwide patent, Vietnam, prosecution, Pharmaceuticals, PCT national stage, Patents, Patent Prosecution, Patent filing, patent, novelty, law, intellectual property, examination, EPO, Drug patents, claims on
May 13, 2009
Patentability of medical use claims in Vietnam has been debated for long time. At certain points of time, a number of Vietnamese patents were granted with medical use claims (first use or second use) following the practice at EPO. However, with the advent of the Code of Intellectual Property 2005, which came into force on July 1, 2006, the question again became hotly arguing.
In applying the Code of Intellectual Property 2005, medical use claims, just like any other use claims, are rejected in Vietnam for failure to be either products or processes, and hence subject to exclusion from patent protection in the country. Patent applicants, especially those in pharmaceutical industries, and their patent agents choose to either: (1) convert the second medical use claims (Swiss type, as named
.jpg)
.jpg)
